跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irprestan Tablet 300 mg - HSA Drug Approval Details
Approvals
/
HSA
/
Irprestan Tablet 300 mg
Approved
THERAPEUTIC
Irprestan Tablet 300 mg
Balkanpharma-Dupnitsa AD
🇸🇬 Health Sciences Authority
Approval Date
Jun 19, 2012
Approval ID
afac23c4d0f0705c
Company
Balkanpharma-Dupnitsa AD
Type
Therapeutic
Approval Details
Approval Id
afac23c4d0f0705c
Drug Name
Irprestan Tablet 300 mg
Product Name
Irprestan Tablet 300 mg
Approval Number
SIN14164P
Approval Date
2012-06-19
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
C09CA04
Atc Item Name
irbesartan
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Irbesartan
300 mg
IRBESARTAN
300 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 19, 2012
Approval ID
afac23c4d0f0705c
Type
Therapeutic
Back to HSA Approvals